Department of Small Animal Clinical Sciences, College of Veterinary Medicine, Michigan State University, East Lansing, MI.
Center for Statistical Training and Consulting, Michigan State University, East Lansing, MI.
Am J Vet Res. 2023 Sep 19;84(12). doi: 10.2460/ajvr.23.07.0160. Print 2023 Dec 1.
(1) Determine if a relationship exists between ionized calcium (iCa) and pancreatic lipase (cPLI) concentration in dogs, and (2) assess for correlation between resolving hypercalcemia and cPLI concentrations in dogs after treatment for primary hyperparathyroidism (PHPT).
Phase I, 44 residual serum samples (collected April 2023) from client-owned dogs with a clinical indication for cPLI quantification. Phase II, 24 residual serum samples (collected August 2022 through February 2023) from client-owned dogs with PHPT pre- and postcorrection of hypercalcemia.
Serum cPLI and iCa concentrations were measured via the Spec cPL assay and a spectrophotometric method respectively. Spearman's rank correlation coefficients were used to investigate if there was a correlation between serum calcium and cPLI concentrations. A paired t-test was used to investigate the effect of the resolution of hypercalcemia on serum cPLI concentrations.
Phase I, serum cPLI concentrations were negatively correlated with serum iCa concentrations (r = -.429, 95% CI [-.64, -.14], P = .005) in dogs with a clinical indication for cPLI quantification. Phase II, median serum cPLI concentrations were higher before (median: 228.5 μg/L, IQR: 351.3 μg/L) than after (median: 141.0 μg/L, interquartile ranges (IQR): 279.5 μg/L) management of hypercalcemia (PHPT model). However, the decrease in cPLI concentration was not statistically significant (P = .70).
Calcium depletion may result in an inverse relationship between serum cPLI and iCa concentrations in dogs with a clinical indication for cPLI quantification. Hypercalcemia may be associated with an above reference interval cPLI concentration in some dogs.
(1)确定犬离子钙(iCa)和胰腺脂肪酶(cPLI)浓度之间是否存在关系,以及(2)评估原发性甲状旁腺功能亢进症(PHPT)治疗后犬高钙血症缓解与 cPLI 浓度之间的相关性。
第 I 阶段,44 份来自有 cPLI 定量临床指征的患犬的残留血清样本(于 2023 年 4 月采集)。第 II 阶段,24 份来自 PHPT 患犬的残留血清样本(于 2022 年 8 月至 2023 年 2 月采集),这些患犬在高钙血症得到纠正前后。
通过 Spec cPL 检测和分光光度法分别测定血清 cPLI 和 iCa 浓度。采用 Spearman 秩相关系数来研究血清钙与 cPLI 浓度之间是否存在相关性。采用配对 t 检验来研究高钙血症缓解对血清 cPLI 浓度的影响。
第 I 阶段,在有 cPLI 定量临床指征的患犬中,血清 cPLI 浓度与血清 iCa 浓度呈负相关(r = -.429,95%置信区间[-0.64,-0.14],P =.005)。第 II 阶段,高钙血症管理后(中位数:141.0 μg/L,IQR:279.5 μg/L)犬的血清 cPLI 浓度中位数高于管理前(中位数:228.5 μg/L,IQR:351.3 μg/L)(PHPT 模型)。然而,cPLI 浓度的下降无统计学意义(P =.70)。
在有 cPLI 定量临床指征的患犬中,钙耗竭可能导致血清 cPLI 和 iCa 浓度之间呈反比关系。一些犬的高钙血症可能与参考区间以上的 cPLI 浓度相关。